Nalka Invest AB entered into a sale and purchase agreement to acquire 90% stake in Onemed AB from 3i Eurofund V, managed by 3i Group plc (LSE:III) and others on January 18, 2019. 3i Group will get approximately £100 million in proceeds. The remaining stake in Onemed will be owned by the management. The transaction is subject to customary antitrust approvals. The transaction was notified to EU Commission on February 5, 2019. The deadline for the decision has been set to March 3, 2019. The transaction was approved by EU Commission on February 28, 2019. The deal is expected to complete in March 2019. Jefferies acted as financial advisor to Onemed AB. Max Axelsson, Alexander Berlin-Jarhamn, Pontus Grönberg, Emma Josberg, Jonas Lagerroos, Erik Larsson, Oscar Liljeson, Johan Steen and Ivana Sutalo of White & Case acted as a legal advisor to Nalka Invest AB.